504 related articles for article (PubMed ID: 11244332)
1. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Kitadai Y; Yoshihara M; Chayama K; Shimamoto F
Oncology; 2002; 62(2):157-66. PubMed ID: 11914602
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
[TBL] [Abstract][Full Text] [Related]
5. MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma.
Aoki R; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Dis Colon Rectum; 1998 Oct; 41(10):1262-72. PubMed ID: 9788390
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Ochiumi T; Tanaka S; Oka S; Hiyama T; Ito M; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2004 Mar; 24(3):539-47. PubMed ID: 14767538
[TBL] [Abstract][Full Text] [Related]
7. Conditions of curability after endoscopic resection for colorectal carcinoma with submucosally massive invasion.
Tanaka S; Haruma K; Oh-E H; Nagata S; Hirota Y; Furudoi A; Amioka T; Kitadai Y; Yoshihara M; Shimamoto F
Oncol Rep; 2000; 7(4):783-8. PubMed ID: 10854544
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Oncology; 2003; 64(1):61-73. PubMed ID: 12457033
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis.
Tanaka S; Haruma K; Teixeira CR; Tatsuta S; Ohtsu N; Hiraga Y; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
J Gastroenterol; 1995 Dec; 30(6):710-7. PubMed ID: 8963387
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer.
Kimura T; Tanaka S; Haruma K; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Int J Oncol; 2000 Jan; 16(1):55-64. PubMed ID: 10601549
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
[TBL] [Abstract][Full Text] [Related]
12. Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.
Nishida T; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(4):340-6. PubMed ID: 7777250
[TBL] [Abstract][Full Text] [Related]
13. Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study.
Schönberger J; Rüschoff J; Grimm D; Marienhagen J; Rümmele P; Meyringer R; Kossmehl P; Hofstaedter F; Eilles C
Thyroid; 2002 Sep; 12(9):747-54. PubMed ID: 12481939
[TBL] [Abstract][Full Text] [Related]
14. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
Kawamura T; Kusakabe T; Sugino T; Watanabe K; Fukuda T; Nashimoto A; Honma K; Suzuki T
Cancer; 2001 Aug; 92(3):634-41. PubMed ID: 11505409
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Younes M; Lechago LV; Lechago J
Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
[TBL] [Abstract][Full Text] [Related]
16. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer.
Goishi H; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncol Rep; 2000; 7(4):713-8. PubMed ID: 10854531
[TBL] [Abstract][Full Text] [Related]
18. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
19. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
Sakashita M; Aoyama N; Minami R; Maekawa S; Kuroda K; Shirasaka D; Ichihara T; Kuroda Y; Maeda S; Kasuga M
Eur J Cancer; 2001 Jan; 37(2):204-9. PubMed ID: 11166147
[TBL] [Abstract][Full Text] [Related]
20. Single carcinoma cells at the deepest invasive portion correlate with metastatic potential of advanced colorectal carcinoma.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Int J Oncol; 1997 Jun; 10(6):1141-5. PubMed ID: 21533496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
